Research & Education

Novel Assay Developed for Detecting ALK Rearrangement in NSCLC

Technique Offers Benefit over Currently Available Methods

DENVER – Researchers have developed a novel technique for detecting ALK rearrangements in non-small cell lung cancers (NSCLCs) that is more sensitive and easier to perform than currently available techniques.

Hormone Therapy Linked to Better Survival after Lung Cancer Diagnosis in Women

DENVER – Survival among people with lung cancer has been better for women than men, and the findings of a recent study indicate that female hormones may be a factor in this difference.

Significant Discrepancies between FISH and IHC Results for ALK Testing

Results Support Need for Combined Testing

DENVER –The findings of a recent study indicate that routine testing with both fluorescent in situ hybridization (FISH) and immunohistochemistry (IHC) may enhance the detection of ALK-positive non-small cell lung cancer (NSCLC).

Clinical Trial Success Influenced by Biomarker- and Receptor-Targeted Therapies in NSCLC

DENVER – Over the past decade, a great clinical focus has been directed at developing new and innovative therapies for advanced non-small cell lung cancer (NSCLC).

High Frequency of EGFR Mutations Found in Asian Population

High Rate across all Asian Subgroups

DENVER – Adenocarcinoma histology, female sex, never-smoking status, and Asian ethnicity have been considered the most important factors associated with EGFR mutations in non-small cell lung cancer and response to EGFR inhibitors.

CEO Statement - IASLC Applauds US Pharmacy’s Decision to Stop Selling Tobacco Products

Aurora, CO – CVS Caremark, a US-based pharmacy chain, announced Wednesday it will stop selling cigarettes and other tobacco products at its CVS/pharmacy stores by October 1.